Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005929 | cilium | 4 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: A0A3S7X154
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006747 | FAD biosynthetic process | 7 | 1 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009117 | nucleotide metabolic process | 5 | 1 |
GO:0009165 | nucleotide biosynthetic process | 6 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0042726 | flavin-containing compound metabolic process | 4 | 1 |
GO:0042727 | flavin-containing compound biosynthetic process | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0046443 | FAD metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072387 | flavin adenine dinucleotide metabolic process | 5 | 1 |
GO:0072388 | flavin adenine dinucleotide biosynthetic process | 6 | 1 |
GO:0090407 | organophosphate biosynthetic process | 4 | 1 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0003919 | FMN adenylyltransferase activity | 6 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
GO:0016779 | nucleotidyltransferase activity | 4 | 1 |
GO:0070566 | adenylyltransferase activity | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.224 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.300 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.508 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.349 |
CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.349 |
CLV_PCSK_PC7_1 | 17 | 23 | PF00082 | 0.246 |
CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.267 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.311 |
CLV_Separin_Metazoa | 43 | 47 | PF03568 | 0.462 |
DEG_APCC_DBOX_1 | 97 | 105 | PF00400 | 0.446 |
DOC_MAPK_MEF2A_6 | 107 | 114 | PF00069 | 0.452 |
DOC_PP1_RVXF_1 | 109 | 115 | PF00149 | 0.506 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.506 |
DOC_USP7_UBL2_3 | 107 | 111 | PF12436 | 0.502 |
DOC_WW_Pin1_4 | 132 | 137 | PF00397 | 0.521 |
LIG_14-3-3_CanoR_1 | 118 | 122 | PF00244 | 0.373 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.486 |
LIG_14-3-3_CanoR_1 | 8 | 16 | PF00244 | 0.387 |
LIG_14-3-3_CanoR_1 | 98 | 102 | PF00244 | 0.446 |
LIG_14-3-3_CterR_2 | 212 | 215 | PF00244 | 0.586 |
LIG_Actin_WH2_2 | 97 | 113 | PF00022 | 0.479 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.378 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.484 |
LIG_FHA_2 | 101 | 107 | PF00498 | 0.509 |
LIG_LIR_Gen_1 | 171 | 181 | PF02991 | 0.503 |
LIG_LIR_Gen_1 | 66 | 76 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 135 | 141 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 171 | 177 | PF02991 | 0.544 |
LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 66 | 71 | PF02991 | 0.437 |
LIG_SH2_CRK | 158 | 162 | PF00017 | 0.434 |
LIG_SH2_CRK | 174 | 178 | PF00017 | 0.426 |
LIG_SH2_NCK_1 | 174 | 178 | PF00017 | 0.516 |
LIG_SH2_SRC | 23 | 26 | PF00017 | 0.330 |
LIG_SH2_STAP1 | 158 | 162 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 14 | 17 | PF00017 | 0.265 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.420 |
LIG_SH3_1 | 133 | 139 | PF00018 | 0.462 |
LIG_SH3_3 | 133 | 139 | PF00018 | 0.506 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.462 |
LIG_UBA3_1 | 15 | 21 | PF00899 | 0.314 |
MOD_CK1_1 | 100 | 106 | PF00069 | 0.502 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.481 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.588 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.371 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.505 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.462 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.354 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.261 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.348 |
MOD_GSK3_1 | 165 | 172 | PF00069 | 0.492 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.439 |
MOD_N-GLC_1 | 9 | 14 | PF02516 | 0.325 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.374 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.488 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.544 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.548 |
MOD_NEK2_1 | 97 | 102 | PF00069 | 0.438 |
MOD_NEK2_2 | 165 | 170 | PF00069 | 0.506 |
MOD_PIKK_1 | 91 | 97 | PF00454 | 0.429 |
MOD_PKA_2 | 117 | 123 | PF00069 | 0.353 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.483 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.506 |
MOD_Plk_4 | 35 | 41 | PF00069 | 0.421 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.490 |
MOD_ProDKin_1 | 132 | 138 | PF00069 | 0.521 |
TRG_AP2beta_CARGO_1 | 66 | 75 | PF09066 | 0.506 |
TRG_DiLeu_BaLyEn_6 | 184 | 189 | PF01217 | 0.436 |
TRG_ENDOCYTIC_2 | 158 | 161 | PF00928 | 0.439 |
TRG_ENDOCYTIC_2 | 174 | 177 | PF00928 | 0.394 |
TRG_ER_diArg_1 | 189 | 191 | PF00400 | 0.397 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7C6 | Leptomonas seymouri | 58% | 86% |
A0A0S4IUQ2 | Bodo saltans | 42% | 93% |
A0A1X0NVD4 | Trypanosomatidae | 46% | 66% |
A4HG68 | Leishmania braziliensis | 87% | 100% |
A4I3B1 | Leishmania infantum | 100% | 100% |
D0A7S9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 67% |
E9AZI8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
O74841 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 32% | 81% |
P38913 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 70% |
Q4Q8P3 | Leishmania major | 97% | 100% |
V5B9Z2 | Trypanosoma cruzi | 46% | 67% |